High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$70.7M
$70,717,429
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-02-13 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-02-13 | $5,298,000Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-01-12 | $4,384,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-01-12 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-09 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.8%
|
2025-12-09 | $4,170,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-09 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-11-07 | $770,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-07 | $4,044,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-11-07 | $4,044,000Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-17 | $1,876,925Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-17 | $2,020,211Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-16 | $5,044,770Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -17.5%
|
2025-10-16 | $5,426,708Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -21.6%
|
2025-10-15 | $7,020,583Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-15 | $6,572,726Whale | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-13 | $328,523 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-13 | $336,814 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-09 | $1,663,299Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-09 | $1,710,522Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-08 | $2,245,352Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-08 | $955,798 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-08 | $163,366 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -19.1%
|
2025-10-07 | $5,735,850Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $798,126 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $1,064,660Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-07 | $696,307 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $73,693 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.2%
|
2025-10-06 | $2,800,611Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $2,018,577Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-10-06 | $185,505 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -28.9%
|
2025-09-23 | $9,061,130Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-22 | $385,000 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -12.5%
|
2025-09-22 | $4,739,568Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-22 | $1,780,140Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-09-22 | $1,501,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-09-19 | $3,850,000Large | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -25.8%
|
2025-09-19 | $10,223,079MEGA | S | Form 4 |